📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Epigenetic nucleotides enhance therapy (2021)

First Author: Kriaucionis S

Attributed to: Determining the contribution of 5-hydroxymethylcytosine to the mutability of DNA funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/science.abh3188

PubMed Identifier: 33833109

Publication URI: http://europepmc.org/abstract/MED/33833109

Type: Journal Article/Review

Parent Publication: Science

Issue: 6538

ISSN: 0036-8075